In vitro studies demonstrated that JNJ-78306358 exhibits peripheral blood mononuclear cell- and T cell- based cytotoxicity against endogenous membrane HLA-G-expressing tumor cell lines with increased potency with increasing HLA-G expression. This evidence concerns the gene HLA-G and neoplasm.